These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 25455159)
41. Dysregulated microRNA-224/apelin axis associated with aggressive progression and poor prognosis in patients with prostate cancer. Wan Y; Zeng ZC; Xi M; Wan S; Hua W; Liu YL; Zhou YL; Luo HW; Jiang FN; Zhong WD Hum Pathol; 2015 Feb; 46(2):295-303. PubMed ID: 25532941 [TBL] [Abstract][Full Text] [Related]
42. Expression profile of microrna-145 in urothelial bladder cancer. Dip N; Reis ST; Srougi M; Dall'Oglio MF; Leite KR Int Braz J Urol; 2013; 39(1):95-101; discussion 102. PubMed ID: 23489501 [TBL] [Abstract][Full Text] [Related]
43. Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma. Wang LJ; Zhang KL; Zhang N; Ma XW; Yan SW; Cao DH; Shi SJ Oncotarget; 2015 Jul; 6(21):18631-40. PubMed ID: 26087181 [TBL] [Abstract][Full Text] [Related]
44. Expression of miRNA-630 in bladder urothelial carcinoma and its clinical significance. Wang ZY; Zhang W; Yang JJ; Song DK; Wei JX J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):705-709. PubMed ID: 27752905 [TBL] [Abstract][Full Text] [Related]
45. Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma. Izquierdo L; Ingelmo-Torres M; Mallofré C; Lozano JJ; Verhasselt-Crinquette M; Leroy X; Colin P; Comperat E; Roupret M; Alcaraz A; Mengual L BJU Int; 2014 May; 113(5):813-21. PubMed ID: 24180461 [TBL] [Abstract][Full Text] [Related]
46. Uncovering the clinical utility of miR-143, miR-145 and miR-224 for predicting the survival of bladder cancer patients following treatment. Avgeris M; Mavridis K; Tokas T; Stravodimos K; Fragoulis EG; Scorilas A Carcinogenesis; 2015 May; 36(5):528-37. PubMed ID: 25804644 [TBL] [Abstract][Full Text] [Related]
47. Differential expression and prognostic value of HMGA1 in pancreatic head and periampullary cancer. van der Zee JA; ten Hagen TL; Hop WC; van Dekken H; Dicheva BM; Seynhaeve AL; Koning GA; Eggermont AM; van Eijck CH Eur J Cancer; 2010 Dec; 46(18):3393-9. PubMed ID: 20724141 [TBL] [Abstract][Full Text] [Related]
48. Identification of microRNA-205 as a potential prognostic indicator for human glioma. Hou SX; Ding BJ; Li HZ; Wang L; Xia F; Du F; Liu LJ; Liu YH; Liu XD; Jia JF; Li L; Wu ZL; Zhao G; Zhang ZG; Deng YC J Clin Neurosci; 2013 Jul; 20(7):933-7. PubMed ID: 23683741 [TBL] [Abstract][Full Text] [Related]
49. miR-26a suppresses osteosarcoma migration and invasion by directly targeting HMGA1. Liu J; Mi B; Wang Y; Shi C; Mi X; Lu Y; Yu P Oncol Lett; 2018 Jun; 15(6):8303-8310. PubMed ID: 29928320 [TBL] [Abstract][Full Text] [Related]
50. HMGA1/HMGA2 protein expression and prognostic implications in gastric cancer. Jun KH; Jung JH; Choi HJ; Shin EY; Chin HM Int J Surg; 2015 Dec; 24(Pt A):39-44. PubMed ID: 26537313 [TBL] [Abstract][Full Text] [Related]
51. Expression and Clinical Significance of miR-26a and Pleomorphic Adenoma Gene 1 (PLAG1) in Invasive Pituitary Adenoma. Yu C; Li J; Sun F; Cui J; Fang H; Sui G Med Sci Monit; 2016 Dec; 22():5101-5108. PubMed ID: 28012286 [TBL] [Abstract][Full Text] [Related]
52. Aberrant Expression of miR-142-3p and its Target Gene HMGA1 and FZD7 in Breast Cancer and its Clinical Significance. Jia XP; Meng LL; Fang JC; Wang HW; Chen J; Zhou J; Wang CN; Jiang WF Clin Lab; 2018 Jun; 64(6):915-921. PubMed ID: 29945308 [TBL] [Abstract][Full Text] [Related]
53. IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells. Panneerselvam J; Srivastava A; Muralidharan R; Wang Q; Zheng W; Zhao L; Chen A; Zhao YD; Munshi A; Ramesh R Oncotarget; 2016 Oct; 7(43):70247-70263. PubMed ID: 27602961 [TBL] [Abstract][Full Text] [Related]
54. Overexpression of ABCC3 promotes cell proliferation, drug resistance, and aerobic glycolysis and is associated with poor prognosis in urinary bladder cancer patients. Liu X; Yao D; Liu C; Cao Y; Yang Q; Sun Z; Liu D Tumour Biol; 2016 Jun; 37(6):8367-74. PubMed ID: 26733163 [TBL] [Abstract][Full Text] [Related]
55. Increased miR-141 expression is associated with diagnosis and favorable prognosis of patients with bladder cancer. Wang XL; Xie HY; Zhu CD; Zhu XF; Cao GX; Chen XH; Xu HF Tumour Biol; 2015 Feb; 36(2):877-83. PubMed ID: 25304156 [TBL] [Abstract][Full Text] [Related]
56. HMGA1 and MMP-11 Are Overexpressed in Human Non-melanoma Skin Cancer. Greco M; Arcidiacono B; Chiefari E; Vitagliano T; Ciriaco AG; Brunetti FS; Cuda G; Brunetti A Anticancer Res; 2018 Feb; 38(2):771-778. PubMed ID: 29374701 [TBL] [Abstract][Full Text] [Related]
57. microRNA-758 inhibits the malignant phenotype of osteosarcoma cells by directly targeting Ren J; Yang M; Xu F; Chen J Am J Cancer Res; 2019; 9(1):36-52. PubMed ID: 30755810 [TBL] [Abstract][Full Text] [Related]
58. The High Mobility Group A1 (HMGA1) gene is highly overexpressed in human uterine serous carcinomas and carcinosarcomas and drives Matrix Metalloproteinase-2 (MMP-2) in a subset of tumors. Hillion J; Roy S; Heydarian M; Cope L; Xian L; Koo M; Luo LZ; Kellyn K; Ronnett BM; Huso T; Armstrong D; Reddy K; Huso DL; Resar LMS Gynecol Oncol; 2016 Jun; 141(3):580-587. PubMed ID: 27001612 [TBL] [Abstract][Full Text] [Related]
59. Non-invasive diagnostic potential of microRNA-203 in liquid biopsy of urothelial carcinoma of bladder. Singh P; Singh A; Gupta N; Raja KD; Singh P; Agarwal S; Sharma A Mol Cell Biochem; 2022 Sep; 477(9):2173-2182. PubMed ID: 35445913 [TBL] [Abstract][Full Text] [Related]
60. Bladder Cancer Patients with Elevated SPRR1B Expression Experiencing a Poor Prognosis. Cheng H; Wang R; Lu L; Gong Y; Li L; Wang Z Arch Esp Urol; 2024 Jun; 77(5):554-569. PubMed ID: 38982785 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]